DAVID GRANOVSKY

Posts Tagged ‘attack’

STEM CELLS FIX HEART 5 YEARS AGO

In VICTORIES & SUCCESS STORIES on November 17, 2013 at 9:18 am

AN UPDATE ON JAMES 11/17/2013

 “i have been doing manual labor with my dads company the heart is doing well im getting in better shape every week.

im to the piont now i can carry 5 gallon buckets of concrete up hills lol, pretty cool still
in a few days it will be my 6 year anniversary and still no reversion!!”
success

2006

Case Study: James Eilert, 34 years old, presents with a “widowmaker” [100 % blockage of the left ascending coronary artery]. His ejection fraction (EF – volume of blood his heart pumps out) was between 20 and 25 percent (55 is normal). His cardiologist told him he has about 5 years left to live.  James left the country in order to receive Adult Stem Cell treatment.

1 1/2 weeks after treatment – Echocardiogram revealed that his completely dead apex was beating again.

6 months after treatment – Sidewalls of heart beat normally.  Septum went from 100% damage to 30% damage. Cardiologist confirms James’ heart is 50 percent more elastic than the year before Repair Stem Cell therapy.

6 – 9 months after treatment – James’ total dead heart tissue is down to about 10%.  EF is up to 50%!

4 years later – James’ heart and health continue to improve. He continues to push himself and his limits.  He runs regularly, works 7 days a week and can bike 20 miles .

Summation:

James went from Class III congestive heart failure to Class I with an ejection fraction (EF) increase from ~20-25% to his current EF of 50%.  His doctors have lifted all restrictions and limitations on his physical activities.

James is only one of many adult stem cell treatment success stories…

November 17, 2011 Update:

A letter from James.  How is he doing today?

“its amazing how fast reality can change, the differences that you see in others that they dont notice themselves. the changes in attitudes and perceptions that the “new” was never in doubt and is accepted as if it were always true. the new studies showing the truth about adult stem cell heart treatments the last few months have proven that we the few pioneers that have made huge financial sacrifices to try and save our lives were not crazy, stupid or otherwise deluded!

it was a risk and for the last four years despite proving over and over by running uphill on so many treadmills my improvments were basically ignored by cardiologists, general practitioners, and even my own wife and stepdaughters.

that i am happy to say has changed!!!!

i went to see my doctor yesterday, he told me to start heavy weight training and interval running, to help me lose weight better. what was differnet? nobody has told me to do that since my heart attack, there was no mention of taking it easy, in fact before i was told to only do light weights and take it easy, watch my heart rate, dont push past 150bpm ever.

it was like i never even had a heart attack.

i asked in disbelief if i should watch my heart rate, keep it a safe zone. the answer “no, stick to 85 to 90 percent and youll be fine, your exercise scores and echos show you can handle it”

vindication, no longer an unexplained anamoly, just a patient that responded better than average to a new treatment – like it was always true in thier minds, never a doubt.

what a feeling!! it has taken ten years to go from the “fringe” to the mainstream – i look forward to getting treatments here in america, and i’m so happy i took the risk that now ensures i will be alive to reap the benifits when it becomes available here!

have a good day david – it nice to be right once in a while!
jim eilert

Congratulations as always Jim!  On your heart recovery success and on having the courage to be a pioneer with an adult stem cell treatment that was cutting edge around the world 5 years ago and is still barely know today in the USA! – David

Advertisements

Patient’s own stem cells help heal heart, early research shows – CNN.com

In CATCH UP!, VICTORIES & SUCCESS STORIES on February 14, 2012 at 3:27 am

7 long years.

It has taken 7 years for the US medical system to CATCH UP to the rest of the world.  This article, though pro-adult stem cell, uses the same tired, B.S. lines like:

“This is the first instance of therapeutic regeneration”

This article blatantly ignores the thousands of of studies, trials and patients successfully treated over the last 7 years.  Sadly, we won’t see stem cell treatments readily, commonly and commercially available in the US for a long time. 

Many people will offer comments on these developments…

The uninformed will say: “first time ever!”

The optimists will say: “better late than never”

The realists will say: “10 years before US patients will have access to these treatments”

The families of those who have died over the past 7 years will say: “if only the US woke up sooner”

……………………

Stem cell treatments are available NOW outside of the United States at some of the most modern and advanced hospitals and clinics in the world.  Maybe, just maybe, the families of those who WILL die from heart disease over the NEXT 10 years will say:

“NOW is the time to go where they have been treating heart disease with stem cells for over half a decade”

For info on CURRENTLY AVAILABLE stem cell treatments for heart disease:

http://bit.ly/stemcellsnow

For more info and the HISTORY of stem cells for heart disease :

https://repairstemcell.wordpress.com/heart-disease-treatment/

Patient's own stem cells help heal heart, early research shows

Patient’s own stem cells help heal heart, early research shows

A patient’s own heart cells can be used to regrow new heart tissue and help undo damage caused by a heart attack, according to early research published on Monday.

Scientists at Cedars-Sinai Medical Center in Los Angeles and Johns Hopkins University in Baltimore were able to treat 17 heart attack patients with cells grown from their own heart tissue and not only show the procedure was safe, but also that the cells can help reduce scarring and even cause new heart muscle to grow.

When a person suffers a heart attack, he or she is often left with huge areas of scarring in the heart. Scarred heart muscle doesn’t pump blood as well as it used to, putting stress on other parts of the heart to make up for the deficit. The damaged area also doesn’t conduct electric current as well, leading to an abnormal heart rhythm, which can cause more problems. Heart attack patients often go on to develop heart failure.

“This is the first instance of therapeutic regeneration,” says Dr. Eduardo Marbán, director of the Cedars-Sinai Heart Institute. He says while nature abounds with examples of spontaneous regeneration of limbs or tissues – like a salamander’s new tail or a human liver regrowing to full size if partially damaged – doctors have not been able to help patients regrow heart tissue. This could change in the future if larger clinical trials and longer patient outcomes confirm the results of this early research published Monday in the journal The Lancet.  Marbán and his colleagues first presented this research at an American Heart Association conference in November…

Patient’s own stem cells help heal heart, early research shows – – CNN.com Blogs.

The Future of Stem Cell Research: BCVS Advances in 2010 – AHA Science Network

In STEM CELLS IN THE NEWS on March 9, 2011 at 1:14 pm

Basic Cardiovascular Science Advances for 2010: The Future of Stem Cell Research

By Dr. Mark Sussman

The mission of our council is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical cardiovascular disease. Special emphasis is placed on integrating molecular/cellular and physiological approaches to address problems relating to functional genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology and peripheral vascular disease. The council plays a major role in linking basic science to clinical science and is concerned with advancing and applying knowledge derived from basic science to the patient.

Annually AHA asks all of its Councils and science groups what in their estimation have been the most important advances in their respective fields within the past year. We have pulled out of all of those suggestions the ones that came from or are relevant to our community. Several studies this year brought the future of medicine closer to the present with new insight into emerging technologies. These studies evaluate the role of stem cells in cardiac repair and their ability to differentiate into cardiac myocytes and the ability of the heart to replace and regenerate myocytes on its own. The findings from stem cell therapy have been shown to improve quality of life and survival in patients with chronic heart failure and support the development of future cell based therapeutics.

Dr. Mark Sussman is the Chair of the BCVS Council. He is the Distinguished Professor of Biology at the SD

CLICK CHART FOR AN ENLARGED VIEW (YOU CAN CLICK TWICE)

Posted by Melissa AHA Science on Mar 9, 2011 9:13 AM CST

Stem-cell experiment on pigs seen as step forward in repairing heart damage

In VICTORIES & SUCCESS STORIES on August 3, 2010 at 9:26 am

“A medical research team led by University of Miami doctors injected stem cells into the hearts of pigs that had been damaged by heart attacks. Within two months, the doctors said, the stem cells made the pigs’ hearts good as new.”

Stem-cell experiment on pigs seen as step forward in repairing heart damage

August 2, 2010 By Fred Tasker

A medical research team led by University of Miami doctors injected stem cells into the hearts of pigs that had been damaged by heart attacks. Within two months, the doctors said, the stem cells made the pigs’ hearts good as new.

For humans, the research represents another promising step toward healing the damage from heart attacks, the No. 1 cause of death in the United States, killing more than 800,000 people a year.

The treatment resulted in rapid healing in the pigs, said Dr. Joshua Hare, a cardiologist at UM Medical School and director of its Interdisciplinary Stem Cell Institute, where research was done.

“In two weeks, their heart function was almost back to normal. In two months, they were absolutely back to normal,” he said. “If we can achieve even 50 percent of that in humans, it will have a major impact.”

Hare said he hopes that within a decade, the procedure might be routine in humans, and that similar therapy might be available for the liver, kidney, pancreas, brain, even for strokes and limbs badly injured in battle.

The new study, published in the July 29 issue of Circulation Research, a journal of the American Heart Association, builds on another UM study published in December. In that study, immature “mesenchymnal” human stem cells extracted from bone marrow and infused into the hearts of human heart-attack victims made their hearts less prone to dangerous arrhythmias and better able to pump blood.

That study prompted widespread debate among scientists over how the stem cells were able to promote healing in the heart. The greatest significance of the new research that it explains the healing process, Hare says.

“Scientists always want to know why,” he said. “You can’t really go forward with research unless you understand what’s going on.”

Dr. Robert Simari, vice chairman of cardiology at the Mayo Clinic in Rochester, Minn., who had read the study but did not take part in it, supported its significance.

“This is a unique insight,” he said. “The field has been hindered by a lack of understanding of this mechanism. This shines new light on how these things work.”

The new UM study found that the stem cells helped the heart in two ways. First, some of the stem cells — injected into the heart via catheter into the groin and up the femoral artery — actually turned into new, healthy heart cells themselves. They replaced heart tissue killed by the heart attack, and became part of the heart muscle that contracts and beats to circulate the blood.

Another part of the injected stem cells didn’t turn into new heart cells but instead induced stem cells already existing in the heart to greatly multiply, building more heart muscle.

Doctors had known the human heart contained some of its own stem cells, whose function is to repair and regenerate the heart. The heart’s stem cells work like the stem cells in hair follicles, which induce the hair to grow back after a haircut, Hare said. But the heart was thought to have too few of them to fully repair itself.

In the new experiment, the injected stem cells caused an explosion of growth in the heart’s own stem cells, which turned into heart muscle cells.

“They helped create 20 times the number of the body’s own heart stem cells,” Hare said.

The study demonstrates another way to use immature human stem cells that avoids the use of embryonic stem cells, which are controversial because creating them destroys human embryos.

Another advantage is that the experiment worked with stem cells from the bone marrow of unrelated donors, which — for reasons not entirely clear yet — do not seem to carry the same risk of rejection by the recipient’s body, which is a serious problem with heart and kidney transplants.

Stem cells extracted from the patient’s own bone marrow also can be used, but they need three weeks of purification and proliferation to be ready, delaying treatment for the ailing heart.

New studies are under way to see which method — using cells from a donor or the patient — works better, Hare said.

(c) 2010, The Miami Herald.
Distributed by McClatchy-Tribune Information Services.

via Stem-cell experiment on pigs seen as step forward in repairing heart damage.

A few stories with Heart

In ALL ARTICLES on May 14, 2010 at 5:09 pm
Mechanism of Improved Cardiac Function After Bone Marrow
Background— Cell therapy is a promising option to improve functional recovery after …… Paracrine mechanisms in adult stem cell signaling and therapy.
circ.ahajournals.org/cgi/content/full/121/18/2001


Stem Cells from Body Fat Improve Outcomes in Heart Attack Clinical
BrainStorm (BCLI) – Bone Marrow Stem Cell Co. Profile Released Stem Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial
stanford.wellsphere.com/general-medicine…/1101067


UH engineers to improve test for cardiovascular disease
UH engineers to improve test for cardiovascular disease Heart Disease · Genetics – Gene Therapy · Alzheimers – Dementia · Stem Cell Research · Diabetes
www.breakthroughdigest.com/…/uh-engineers-to-improve-test…


Improving Patient Outcomes in Chronic and Acute Heart Studies
Improving Patient Outcomes in Chronic and Acute Heart Studies, International Symposium on Stem Cell Therapy & Cardiovascular Innovation in Madrid Spain.
www.scimitarequity.com/…/improving-patient-outcomes-in-ch…

Stem Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial

In VICTORIES & SUCCESS STORIES on May 7, 2010 at 4:31 pm

Cytori Reports Stem & Regenerative Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial; Plans Underway for European Multicenter Pivotal Trial

SAN DIEGO, May 07, 2010 (BUSINESS WIRE) — The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump…

via Cytori Reports Stem & Regenerative Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial; Plans Underway for European Multicenter Pivotal Trial – MarketWatch.

Blocked Arteries Not Always Found on Angiograms | PreDisease.com Blog

In BUSINESS OF STEM CELLS on March 25, 2010 at 5:57 pm

Blocked Arteries Not Always Found on Angiograms

by Jennifer Bunn, RN

Angiograms are the definitive test for people who may have had a heart attack, or who suffer from chest pain. A normal angiogram virtually rules out the possibility of a heart attack. However, a new study finds that this invasive and expensive test yields far fewer positive results than previously thought.

Researchers studied almost 399,000 patients seen in 663 hospitals over a four-year period. What they found was surprising: only 38% of those undergoing angiograms were found to have blocked arteries. Those patients who had had non-invasive tests prior to angiogram with a positive finding (such as an abnormal stress test) were moderately more likely to have blockage of their arteries discovered on angiogram. Researchers noted that risk factors for finding blockage on angiogram were the same risk factors for cardiovascular disease, including:

* Being male

* Being of older age

* Being diabetic

* Having elevated cholesterol levels

Given that angiograms are both expensive and invasive, it would seem that more stringent criteria is needed to determine who requires an angiogram and who does not. It may be that the culture of practicing defensive medicine is responsible for the number of angiograms done on people with normal findings. It is important to keep in mind that angiograms themselves are not without risk, including the risk of bleeding, and should be reserved for those who truly need it.

Source: Obstructive Disease Not Found on Most Angiograms

via Blocked Arteries Not Always Found on Angiograms | PreDisease.com Blog.

STEM CELL TREATMENT for HEART DISEASE

In VICTORIES & SUCCESS STORIES on March 16, 2010 at 6:49 pm

The information below will educate you on the available Repair Stem Cell treatments for heart disease and the scientific data proving their safety, efficacy, benefits and success.

TREATMENT of HEART DISEASE with STEM CELLS: EDUCATIONAL OVERVIEW

1.  REPAIR STEM CELLS vs. HEART DISEASE – UNDENIABLE SCIENTIFIC EVIDENCE

VESCELL HEART DISEASE TRIAL – 2004 to 2006 –

Clinical trial illustrates the safety and efficacy of VesCell Repair Stem Cell treatment. Accepted by the American Heart Assn in 2005-6. This trial was a key element in attaining regulatory approval for the treatment protocol that improved the lives of 300 mostly “no-option” heart patients.

BRITISH JOURNAL OF HAEMOTOLOGY – 2006

Research paper shows that peripheral blood derived stem cells can differentiate into a variety of other stem cells (angiogenic, myocardial and neural lineages) and do so in sufficient quantities to use as autologous treatment for a variety of diseases.

BIOPROCESSING JOURNAL – 2007

Bioprocessing Journal scientific paper shows the consistent and reliable manufacturing procedure utilized by VesCell for transforming bone marrow and blood-derived stem cells into angiogenic cell precursors (ACPs) and hematopoietic stem cell (HSC) cellular products for the treatment of severe heart diseases.  End product was found to be a) safe and effective; b) prepared from non-mobilized peripheral blood; c) stable, with a relatively long shelf-life; and d) ready-to-use and easily utilized by the physician.

ANGIOGENIC CELL CLINICAL STUDY – 106 CASES – 2005 to 2008

Clinical study at Chao Phya Hospital Heart Center and Siriraj Hospital H.M. Cardiac Center clinical study shows that transcoronary injection of angiogenic cells precursors improved cardiac/left ventricular ejection fraction (LVEF), exercise capacity and quality of life with high safety profile for 70% of ischemic cardiomyopathy patients with no-option revascularization.

CARDIOMYOPATHY TRIAL – 55 CASES – 2005 to 2006

Bangkok Heart Hospital and U of Pittsburgh Medical Center/McGowan Institute for Regenerative Medicine clinical trial shows that VesCell type expanded autologous blood derived stem cells utilized in intramyocardial transplantation is feasible and safe in severely ill patients with intractable heart failure in all cases of dilated cardiomyopathy (DCM) and in both first-time and “redo” ischemic cardiomyopathy (ICM) patients.

PERIPHERAL ARTERY DISEASE – SCIENTIFIC PAPER – 6 CASES

Shows the safety, and feasibility and enhancement of limb salvage from implantation of non-mobilized peripheral blood angiogenic cell precursors (NMPB-ACPs) in 80% of patients with critical limb ischemia (CLI) who were poor candidates for standard revascularization treatment options.

2.  HEART DISEASE CLINICAL STUDIES – A BRIEF HISTORY

2002

A clinical trial led by Dr. Hans Dohmann plus six colleagues in Brazil took 21 transplant candidates and gave 14 of them bone marrow cells. The results were so spectacular that the American Heart Association accepted the paper and it was presented in 2003. Five of the seven in the control group opted in to make a total of 19 stem cell transplants. The mortality rate for transplant candidates is about 35% per year. At that rate there would be, of those 19, only 2.2 patients still alive without a transplant after five years. There were, in fact, 12 alive as of Dec. 31, 2007; more than five years down the road.

1. If you did not want or could not get a heart transplant (as is true of 90%+ of dying heart patients in North America) then you had to make a choice between stem cell treatment or standard Western Cardiology methodology.

2. Western Cardiology methodology kept 12% of patients (waiting for heart transplants) alive for five years.

3. Adult/repair Stem cell treatments kept 63% of patients (waiting for heart transplants) alive for five years.  More than 5 times more heart transplant candidates lived for 5 years with stem cell treatments than the typical heart transplant recipient! Btw, stem cell science has made huge advancements in treating heart disease over the past seven years.

2003

Dr. Andreas Zeiher of the Goethe Institute in Frankfurt began much larger trials. As of 2007, he has overseen more ASC implants into hearts than anyone, both in and out of clinical trials and he was the first to prove that timely implant of RSC in new heart attack victims improves future mortality and morbidity – http://circ.ahajournals.org/cgi/search?journalcode=circulationaha&fulltext=zeiher

2004

1. Dr. Amit Patel of Pittsburgh completed two of the most successful trials ever.  In Uruguay, he proved, on a group of ischemic heart failure patients, that a bypass plus cells was infinitely better than a bypass only. That same year, TheraVitae, in Israel, developed a new, powerful blood-derived stem cell and dared to treat the sickest patients no clinical trial (except Brazil) would consider.

2. One of the Brazilians, Dr. Perin, came to Texas, used the Brazil results to get the first ASC heart clinical trial approved by the FDA. Over a dozen such approvals were granted in the next 12-18 months.

3. The first-ever commercial stem cell treatment center in the world starts adult stem cell treatment of hundreds of human patients.  Results are amazing and include the regrowing of cardiac muscle tissue in patients, significant increases and sometimes a doubling of ejection fractions (the % volume of blood the heart can pump out per beat), etc!  Stem cells are also recognized as “smart,” going to where they were needed most, creating micro-vessel bypasses around existing blockages areas, areas that previously were blocked and in areas where stents were implanted.

2005

Dr Taylor removed all cells from rat hearts except for a thin skeleton of tissue translucent as wax paper. She then injected the scaffold with fresh Cardiac Repair Stem Cells from newborn rats.  Four days later, “We could see these little areas that were beginning to beat.  By eight days, we could see the whole heart beating.”  The experiment, reported in the journal Nature Medicine, marked the first time scientists created a functioning heart in the lab from biological tissue.

2006

Case Study: James Eilert, 34 years old, presents with a “widowmaker” [100 % blockage of the left ascending coronary artery]. His ejection fraction (EF – volume of blood his heart pumps out) was between 20 and 25 percent (55 is normal). His cardiologist told him he has about 5 years left to live.  James left the country in order to receive Repair Stem Cell treatment.

  • · 1 1/2 weeks after treatment – Echocardiogram revealed that his completely dead apex was beating again.
  • · 6 months after treatment – Sidewalls of heart beat normally.  Septum went from 100% damage to 30% damage. Cardiologist confirms James’ heart is 50 percent more elastic than the year before Repair Stem Cell therapy.
  • · 6 – 9 months after treatment – James’ total dead heart tissue is down to about 10%.  EF is up to 50%!
  • · 4 years later – James’ heart and health continue to improve. He continues to push himself and his limits.  He runs regularly, works 7 days a week and can bike 20 miles .

Summation:

  • · James went from Class III congestive heart failure to Class I with an ejection fraction (EF) increase from ~20-25% to his current EF of 50%.  His doctors have lifted all restrictions and limitations on his physical activities.
  • · James is only one of many adult stem cell treatment success stories.

2009

Clinical trials at the Mayo Clinic in Florida have seen successes in reversing and curing pulmonary hypertension using adult stem cells from patients’ own blood.

2010

Hundreds of heart disease patients have experienced improved quality of life, increased ejection fractions, increased energy and stamina.  Many have reduced their prescription drugs and even reduced their insulin requirements.

————————–

Relevant Cardiac/Stem Cell Articles:

3.  HEART DISEASE TREATMENT – INFORMATION REQUEST

If you or a loved one interested in receiving FREE information on currently available stem cell treatments for HEART DISEASE, please contact me at dsgrano@gmail.com or for other options, go to: TREATMENT INFORMATION

—————————————————————

Congratulations on taking your heart health into your own hands!

* To purchase the fully illustrated stem cell book which details the treatment of heart disease with Repair Stem Cells in a fun and educational format, go here – http://bit.ly/StemCellBook4Kids or you can purchase it from the author directly by contacting David Granovsky – dsgrano@gmail.com

Please let me know if we can be of further assistance!  If you have any questions, feel free to ask and please keep us informed on your progress.

Man Receives His Own Stem Cells as a Treatment for Heart Failure

In VICTORIES & SUCCESS STORIES on March 11, 2010 at 4:52 pm

THE TIDE IS TURNING

This story is HUGE.  No, not because a guy got better from stem cells…that’s been goi ng on commercially for half a decade around the world and was proven safe and effective in testing and studies on humans for over a decade.  What’s amazing about this story is that:

a human patient received ADULT stem cells in the US and the story was reported by a major US science publication in a positive light.

To explain;

  • for years the US news sources were unable or incapable or ordered not to publish any positive stories about ADULT stem cells.
  • There were falsely reported positive hyped stories about embryonic stem cell success everywhere…
  • There were positive stories about induced pluripotent stem cells…
  • then there were negative stories about induced pluripootent stem cells…
  • and when the negative induced pluripotent stem cell stories came out, someone decided to rename THOSE stem cells ADULT so as to confuse everyone and cast a negative light on ADULT stem cells…
  • and there were positive ADULT stem cell stories because you just can’t hold back the tide of positive stories from around the world – but these stories never ever had the word ADULT  associated with positive results so the reader had to assume the story was about embryonic…
  • but there were NEVER positive ADULT stem cell stories where the reporter called them ADULT stem cells.
  • This may in fact be the first!

WELL DONE! Keep up the good work!

Now maybe the US can start to catch up on using ADULT stem cells for treatment…seeing as how the EXACT content of this story has already been repeated around the world for almost a decade now. -dg

Man Receives His Own Stem Cells as a Treatment for Heart Failure

By Mandy Kendrick – Jul 27, 2009 03:45 PM

The first person to receive a new cardiac stem cell treatment in a U.S. Food and Drug Administration clinical trial is doing well, it was announced last week.

On Friday, doctors at the University of Louisville School of Medicine, in collaboration with the nearby Jewish Hospital, issued a press release stating that one week after treatment, Mike Jones’s heart was getting stronger.

Jones, whose heart tissue is permanently scarred and weakened by two previous heart attacks, suffers from congestive heart failure, a condition affecting about five million Americans each year, according to the National Institutes of Health.

Currently, two treatment options predominate for patients with heart failure, said Mark Slaughter, a cardiovascular surgeon who aided in the trial. A person can receive a heart transplant or a mechanically assisted heart device.

The new approach, using a patient’s adult stem cells to regenerate healthy heart tissue, is currently in phase I clinical trials to test for safety. The procedure consists of removing healthy heart tissue from the patient, purifying the stem cells from the material, and allowing the stem cell population to grow. Once ready, the stem cells are reintroduced into the scarred region of the heart using a minimally invasive technique.

Since the re-injection of his own stem cells on July 17, Jones’s heart has increased its ability to pump blood by about 5 percent. Jones commented in the University of Louisville School of Medicine press release that he felt so good he might “even start jogging again.”

The doctors will continue monitoring Jones every few months for the next two years to measure his recovery. There are currently 13 more patients going through the phase I trial, and the researchers hope to eventually test a total of 20 patients.

Last month, a group at the Cedars-Sinai Heart Institute in Los Angeles made news with a similar technique that was undergoing clinical trials.  Instead of using purified stem cells, the group is using a mixture of cells, including stem cells, to regenerate heart tissue. Ken Miles, the first patient to receive the treatment, told CBS’s The Early Show that he “feels great.”

New Heart, New Love, New Son Courtesy of Adult Stem Cells

In VICTORIES & SUCCESS STORIES on March 8, 2010 at 3:50 pm
Don’t miss any important stem cell news! Follow me on twitter! http://twitter.com/stemcellblogger
New Heart, New Love, New Son Courtesy of Adult Stem Cells

Ten years ago a Surfers Paradise manss life was dominated by heart disease and time was running out. Now he has been granted a new wife and baby son better health total happiness.

Peter Irwin from Surfers Paradise in Queensland, Australia, has much to be thankful for. Ten years ago he was depressed, ill and deeply unhappy. He suffered from both Dilated Cardiomyopathy and some Ischemic Heart Disease that was slowly but surely killing him. Told there was nothing more that could be done for him and with no hope of living beyond another two years he started to seek for someone or something that could give him better odds.

An internet search unearthed that adult stem cells can offer hope and help. Peter failed to get on to a clinical trial in his own country because he was too ill to meet their entry criteria and so he went to Bangkok in October 2005 thinking he had nothing to lose.

Within four months of a simple procedure at a Bangkok Heart Hospital Peter was feeling much better and far more optimistic. His cardiologist had to agree that on clinical tests his heart was performing far more efficiently. His life since then has continued to improve. He still has some health issues but they no longer dominate his life. The greatest improvement has been that he can enjoy a far better quality of life and has high expectations of a very positive future.

Adult stem cell therapy helped his heart strengthen, revascularize and repair and he made other dietary and lifestyle changes that he thinks have also benefited him. If you are beyond hope of treatment because of heart disease, all is not lost, he said. Almost every day research is being published that shows just how many seriously ill heart patients can be returned to a life they thought they had lost.

To cap off all his gains Peter and his new wife have just recently brought into the world a new son. “Stem cells made me reconsider my life. I now have the love and care of a new partner and a son whom I love more than I thought it possible to love. It is indeed a miracle and I am so grateful”, Peter said.

Looking at the family photographs he sent at the time of his son’s birth Peter looks the picture of health and happiness. One would never know that such a short time ago he faced a brief, painful, anxious, hopeless and debilitating future.

Jon Bradshaw writes constantly about the next to miraculous effects of adult stem cells. Theravitae’s Vescell adult stem cells the new frontier of regenerative medicine. They offer a return to a more active, longer and healthier life to patients who have heart disease or PAD. They are derived from the patient’s own blood so cannot be rejected by the body.

%d bloggers like this: